Skip to main content
Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
705.65
-2.85 (-0.40%)
At close: Mar 9, 2026

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 18.76B INR in the quarter ending December 31, 2025, with 10.84% growth. This brings the company's revenue in the last twelve months to 72.67B, up 13.20% year-over-year. In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B with 7.12% growth.

Revenue (ttm)
72.67B
Revenue Growth
+13.20%
P/S Ratio
1.92
Revenue / Employee
4.39M
Employees
16,571
Market Cap
139.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alivus Life Sciences 25.12B
Cohance Lifesciences 10.79B
NATCO Pharma 45.63B
Eris Lifesciences 30.65B
Piramal Pharma 88.71B
Wockhardt 31.74B
Strides Pharma Science 47.26B
Akums Drugs and Pharmaceuticals 42.60B
Revenue Rankings

Alembic Pharmaceuticals News

More News